In Study Across 15 Centers, 35% of Patients With MCL See Progression After CAR T-Cell Therapy

Study reveals one-third of mantle cell lymphoma patients in a study at leading cancer centers experienced disease progression after CAR T-cell therapy, highlighting treatment challenges and outcomes.